Nectar Lifesciences Sells API Business and Menthol Assets in Major Strategic Shift

Unknown Apr 02, 2026 450 Views

Nectar Lifesciences Ltd has announced two significant asset sales, marking a major transformation in its business portfolio. The company’s board has approved the sale of its active pharmaceutical ingredients (API) and formulations business for Rs 12.7 billion, along with the sale of its men...